Financial Data and Key Metrics Changes - For Q4 2025, normalized FFO increased 42.7% over the prior quarter to $104.1 million, and normalized FAD increased 38.7% to $103 million [16] - On a per-share basis, normalized FFO increased $0.07, or 17.5%, to $0.47 per share, and normalized FAD increased $0.05, or 12.2%, to $0.46 per share [16] - For the full year, normalized FFO per share increased $0.26, or 17.3%, to $1.76 per share, and normalized FAD increased $0.22, or 14.3%, to $1.76 per share [16] Business Line Data and Key Metrics Changes - In Q4, approximately $562 million of investments were completed, including the first SHOP deal involving three communities in Texas with 270 assisted living and memory care units [12] - The blended stabilized yield on Q4 investments was 8.8% [12] - Since year-end, another approximately $215 million of investments were closed, including 6 skilled nursing facilities and 2 care homes in the UK [13] Market Data and Key Metrics Changes - The investment pipeline remains strong at approximately $500 million, with about half in UK care homes, a third in skilled nursing, and the remainder in a small SHOP deal and loans [14] - The competition in the SHOP segment is noted to be the most intense, with cap rates compressing as investors seek exposure to operating trends [14][35] Company Strategy and Development Direction - The company aims to be a unique healthcare REIT focused on disciplined investments in assets and operators that can significantly impact senior housing and care [11] - The strategic push into the UK care home market and the expansion of SHOP capabilities are key growth engines for the company [10][15] - The company is committed to maintaining a strong balance sheet while pursuing external growth opportunities [19][60] Management's Comments on Operating Environment and Future Outlook - The skilled nursing operating environment is described as stable and supportive, with operators eager to return to growth mode [9][25] - Management expresses confidence in achieving substantial growth in 2026, supported by a deeper and more capable team and new market opportunities [10][42] - The company anticipates a year-over-year increase in normalized FFO per share guidance for fiscal year 2026 of $1.90-$1.95, representing a 9.4% increase [18] Other Important Information - The company sold 6.5 million shares on a forward basis at an average price of $37.30, generating gross proceeds of approximately $242.5 million [17] - The company maintains low leverage with net debt to EBITDA of 0.7 times and a fixed charge coverage ratio of 10.5 times as of year-end [19] Q&A Session Summary Question: Guidance and expectations for the pipeline going forward - Management indicated that they are seeing consistent inbound interest in SHOP deals and are evaluating both large and small opportunities [22][23] Question: Sustainability of coverage levels in skilled nursing facilities - Management believes the skilled nursing environment is currently strong, with operators ready to grow and occupancy levels providing room for improvement [25] Question: Focus of data analytic hires - The data science team is primarily focused on enhancing SHOP capabilities but will impact the entire organization [30] Question: Details on the investment pipeline - The pipeline consists of approximately half UK care homes, a third US skilled nursing, and a mix of SHOP and other deals [34] Question: Competitive landscape in property types - SHOP is noted as the most competitive segment, with significant capital pursuing deals [35] Question: Future funding strategies - Management plans to balance between equity issuances and utilizing balance sheet capacity as opportunities arise [59]